My clinical interests include the management of patients with alcoholic and non-alcoholic fatty liver disease and critically-ill cirrhotic patients. I have worked the last ten years in a multidisciplinary team to treat patients with alcoholic liver disease. My main research interests include liver fibrosis and the mechanisms and determinants of mortality of alcoholic liver disease. I have mostly performed translational studies including human samples and experimental models of liver disease. Also, I recently started a line of research on global public health aspects of alcoholic liver disease. I am currently the overall PI of a NIH-funded consortium (InTeam) for translational research of alcoholic hepatitis. The main goals of the InTeam consortium are the identification of molecular subtypes and the identification of novel targets for therapy.